ReviewJournal of medicinal chemistry2023

What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.

Carolyn J Straub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.